Form EFFECT Checkpoint Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 4, 2025 |
| Accession Number: | 0001104659-25-054634 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Beijing Review: From the Pacific to the World: A New Generation in Dialogue
- Freecast's 5,000%+ Transactional Growth to translate into explosive revenues, Starlink & DIRECTV Partnerships, 210 DMAs
- 7 Partner-Led CRM Platforms Recommended for Channel Workflows in Southeast Asia
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
